United Services Automobile Association Xenon Pharmaceuticals Inc. Transaction History

United Services Automobile Association

  • $3.88 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$8.74 - $10.51 $883,080 - $1.06 Million
-101,039 Closed
0 $0
Q2 2019

Aug 16, 2019
BUY
$8.51 - $10.75 $20,424 - $25,800
2,400 Added 2.43%
101,039 $996,000
Q1 2019

May 13, 2019
BUY
$6.39 - $10.42 $630,303 - $1.03 Million
98,639 New
98,639 $1 Million

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email